BSX three-lens brief
Evidence-based stock research on BSX. Three independent lenses — Quality, Momentum, Context — examine live data from SEC filings, the Federal Reserve, and market feeds. Every claim traces to its primary source.
Underperforming SPY by 28.3pp over 30 days. · Trading at 3% of its 52-week range — deep in the lower band.
- Trading at 3% of its 52-week range — deep in the lower band.
- Underperforming SPY by 28.3pp over 30 days.
- Analyst mean target $85.19 — 48% above current (32 analysts).
- Debt-to-equity of 42.3 — balance-sheet-heavy.
BSX closed at $57.60 (+1.95%) as of 2026-05-04. Market cap: $85.60B. P/E (trailing) 24.1. Positives: analyst mean target $85.19 — 48% above current (32 analysts).. Concerns: trading at 3% of its 52-week range — deep in the lower band.; underperforming SPY by 28.3pp over 30 days.. Last quarter: Revenue $5.20B, net income $1.34B, free cash flow $2.81B.
Why three lenses on BSX, not one.
A single reasoning model has blind spots it doesn’t know about. We examine BSXacross Quality (fundamentals), Momentum (price action and sentiment), and Context (macro/sector). Disagreement between lenses is surfaced, not hidden — it’s how you know when HOLD is the honest call.
Read the full methodologyDrop it in your newsletter or blog.
Free to embed. Updates every 6 hours. Links back to the full brief.
<iframe src="https://clearpathinvest.app/embed/BSX" width="100%" height="420" frameborder="0" loading="lazy" title="ClearPath BSX brief"></iframe>